RESEARCH

PROLIGHT: Financing and partner interest strengthen case ahead of regulatory study

Analys, Research

Johan Widmark | 2025-08-29 08:00 READ REPORT IN PDF In Q2, Prolight reported initial positive data...

Read More

CRUNCHFISH: Improved outlook with NPCI adoption and global validation

Analys, Research

Crunchfish’s new go-to-market strategy for offline payments, splitting the solution into...

Read More

PROLIGHT: Positive patient data and patent approval strengthen case for Psyros

Analys, Research

Johan Widmark | 2025-06-18 08:00 READ REPORT IN PDF Key milestone for readiness Prolight has...

Read More

CRUNCHFISH: Third time a charm? New offline strategy targets system integration

Analys, Research

With its third attempt to scale offline payments in India, Crunchfish hopes that its new Offline...

Read More

PROLIGHT: Gearing up for commercialisation with strong insider backing

Analys, Research

Johan Widmark | 2025-05-23 08:00 READ REPORT IN PDF Strong insider commitment signals confidence As...

Read More

NANEXA: Clinical milestones align ahead of phase Ib/II and licensing push

Analys, Research

Nanexa continues to strengthen the foundation for the upcoming Phase Ib/II study in the NEX-22...

Read More

PROLIGHT: Positive results from the pre-clinical validation study de-risk the full clinical validation

Analys, Research

Following the many recent grants, notices of allowance and intention to grant patents in Europe and...

Read More

CINDRIGO HOLDINGS: Lower risk with first revenues, Germany secured and LSE Main Market listing

Research

Johan Widmark | 2025-03-10 10:30  Read the report in PDF here With production now commenced at the...

Read More